Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Etiology, clinical presentation, and diagnosis of chylothorax

INTRODUCTION

Chylothorax is caused by disruption or obstruction of the thoracic duct or its tributaries that results in leakage of chyle (lymphatic fluid of intestinal origin) into the pleural space. Chylous ascites can also flow into the pleural space. The fluid typically has a high triglyceride content and often a turbid or milky white appearance. In contrast, a cholesterol pleural effusion, which can also have a milky appearance, has a high concentration of cholesterol or lecithin-globulin complexes that accumulate due to pleural inflammation or infection.

Understanding of the anatomy of the thoracic duct, the constituents of chyle, and the diverse etiologies of chylothorax is important to the accurate and efficient diagnosis of chylothorax.

The etiology, clinical presentation, and diagnosis of chylothorax will be reviewed here. The management of chylothorax, the evaluation and management of cholesterol effusions, and general issues regarding the evaluation and treatment of pleural effusions are discussed elsewhere. (See "Management of chylothorax" and "Clinical presentation, diagnosis and management of cholesterol effusions" and "Diagnostic evaluation of a pleural effusion in adults: Initial testing" and "Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology" and "Imaging of pleural effusions in adults" and "Mechanisms of pleural liquid accumulation in disease".)

CHYLOTHORAX VERSUS CHOLESTEROL EFFUSION

Cholesterol effusions and chylothoraces both classically have a milky or opalescent appearance. However, their etiologies and therapy differ, making it important to distinguish them.

A chylothorax occurs when lymph fluid accumulates in the pleural space due to disruption or obstruction of the thoracic duct. Chylothoraces contain a high concentration of triglycerides as chylomicrons, unless the patient has no dietary fat ingestion [1-4].

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Apr 8, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Roy, PH, Carr, DT, Payne, WS. The problem of chylothorax. Mayo Clin Proc 1967; 42:457.
  2. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997; 10:1157.
  3. Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo FJ, Gurrutxaga N. Pseudochylothorax. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999; 78:200.
  4. Agrawal V, Sahn SA. Lipid pleural effusions. Am J Med Sci 2008; 335:16.
  5. COE JE, AIKAWA JK. Cholesterol pleural effusion. Report of 2 cases studied with isotopic techniques and review of the world literature. Arch Intern Med 1961; 108:763.
  6. Hillerdal G. Chyliform (cholesterol) pleural effusion. Chest 1985; 88:426.
  7. Valentine VG, Raffin TA. The management of chylothorax. Chest 1992; 102:586.
  8. Doerr CH, Miller DL, Ryu JH. Chylothorax. Semin Respir Crit Care Med 2001; 22:617.
  9. Weidner WA, Steiner RM. Roentgenographic demonstration of intrapulmonary and pleural lymphatics during lymphangiography. Radiology 1971; 100:533.
  10. Macfarlane JR, Holman CW. Chylothorax. Am Rev Respir Dis 1972; 105:287.
  11. Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80:867.
  12. Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii4.
  13. McWilliams A, Gabbay E. Chylothorax occurring 23 years post-irradiation: literature review and management strategies. Respirology 2000; 5:301.
  14. Lee YC, Tribe AE, Musk AW. Chylothorax from radiation-induced mediastinal fibrosis. Aust N Z J Med 1998; 28:667.
  15. Blankenship ME, Rowlett J, Timby JW, et al. Giant lymph node hyperplasia (Castleman's disease) presenting with chylous pleural effusion. Chest 1997; 112:1132.
  16. Ten Hoor T, Hewan-Lowe K, Miller JI, Moss M. A transitional variant of Castleman's disease presenting as a chylous pleural effusion. Chest 1999; 115:285.
  17. Diaz-Guzman E, Culver DA, Stoller JK. Transudative chylothorax: report of two cases and review of the literature. Lung 2005; 183:169.
  18. Maldonado F, Tazelaar HD, Wang CW, Ryu JH. Yellow nail syndrome: analysis of 41 consecutive patients. Chest 2008; 134:375.
  19. Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123:623.
  20. Fernandez FG, Denlinger CE, Patterson GA, et al. Massive bilateral chylothoraces complicating mediastinal granulomatous disease. Ann Thorac Surg 2009; 88:1012.
  21. Karapolat S, Sanli A, Onen A. Chylothorax due to tuberculosis lymphadenopathy: report of a case. Surg Today 2008; 38:938.
  22. Tutor JD, Schoumacher RA, Chesney PJ. Chylothorax associated with histoplasmosis in a child. Pediatr Infect Dis J 2000; 19:262.
  23. Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998; 132:1064.
  24. Ferguson MK, Little AG, Skinner DB. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 1985; 40:542.
  25. Terzi A, Furlan G, Magnanelli G, et al. Chylothorax after pleuro-pulmonary surgery: a rare but unavoidable complication. Thorac Cardiovasc Surg 1994; 42:81.
  26. Ziedalski TM, Raffin TA, Sze DY, et al. Chylothorax after heart/lung transplantation. J Heart Lung Transplant 2004; 23:627.
  27. Zabeck H, Muley T, Dienemann H, Hoffmann H. Management of chylothorax in adults: when is surgery indicated? Thorac Cardiovasc Surg 2011; 59:243.
  28. Johnson TJ, Jamous FG, Kooistra A, Zawada ET. Iatrogenic chylothorax due to pleural cavity extravasation of total parenteral nutrition in two adults receiving nutrition through a peripherally inserted central catheter. Hosp Pract (1995) 2010; 38:50.
  29. Vincent RP, Barron JL, Mulleague L. Differential diagnosis of chylothorax in a patient on parenteral nutrition: a case report. Ann Clin Biochem 2010; 47:84.
  30. Prakash, UBS. Chylothorax and pseudochylothorax. Eur Respir Mon 2002; 7:249.
  31. Lim KG, Rosenow EC 3rd, Staats B, et al. Chyloptysis in adults: presentation, recognition, and differential diagnosis. Chest 2004; 125:336.
  32. Sarsam MA, Rahman AN, Deiraniya AK. Postpneumonectomy chylothorax. Ann Thorac Surg 1994; 57:689.
  33. Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339:314.
  34. Maldonado F, Hawkins FJ, Daniels CE, et al. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84:129.
  35. Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980; 55:700.
  36. Sassoon CS, Light RW. Chylothorax and pseudochylothorax. Clin Chest Med 1985; 6:163.
  37. Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 2010; 31:743.
  38. McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010; 104:1.
  39. Ryu JH, Tomassetti S, Maldonado F. Update on uncommon pleural effusions. Respirology 2011; 16:238.
  40. Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest 2008; 133:1436.
  41. Duntley P, Siever J, Korwes ML, et al. Vascular erosion by central venous catheters. Clinical features and outcome. Chest 1992; 101:1633.
  42. Park JG, Aubry MC, Godfrey JA, Midthun DE. Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc 2006; 81:1197.
  43. Hunt JP, Wilson M, Buchmann LO. Chylothorax associated with substernal goiter treated with transcervical thyroidectomy. Thyroid 2011; 21:551.
  44. Mine S, Udagawa H, Kinoshita Y, Makuuchi R. Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact Cardiovasc Thorac Surg 2008; 7:1186.
  45. Deso S, Ludwig B, Kabutey NK, et al. Lymphangiography in the diagnosis and localization of various chyle leaks. Cardiovasc Intervent Radiol 2012; 35:117.
  46. Plotnik AN, Foley PT, Koukounaras J, Lyon SM. How I do it: Lymphangiography. J Med Imaging Radiat Oncol 2010; 54:43.
  47. Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol 2011; 52:305.
  48. Kos S, Haueisen H, Lachmund U, Roeren T. Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage. Cardiovasc Intervent Radiol 2007; 30:968.
  49. Matsumoto T, Yamagami T, Kato T, et al. The effectiveness of lymphangiography as a treatment method for various chyle leakages. Br J Radiol 2009; 82:286.
  50. Momose M, Kawakami S, Koizumi T, et al. Lymphoscintigraphy using technetium-99m HSA-DTPA with SPECT/CT in chylothorax after childbirth. Radiat Med 2008; 26:508.
  51. Suga K, Kume N, Hara A, et al. Abnormal lymphatic flow demonstrated by lymphoscintigraphy in chylothorax correlation with lymphography. Clin Nucl Med 1999; 24:716.
  52. Ogi S, Fukumitsu N, Uchiyama M, Mori Y. A case of chylothorax diagnosed by lymphoscintigraphy using Tc-99m HSA-DTPA. Clin Nucl Med 2002; 27:455.
  53. Stavngaard T, Mortensen J, Brenoe J, Svendsen LB. Lymphoscintigraphy using technetium-99m human serum albumin in chylothorax. Thorac Cardiovasc Surg 2002; 50:250.
  54. Restrepo JM, Caride VJ. Lymphoscintigraphy and radionuclide venography in chylothorax. Clin Nucl Med 2004; 29:440.